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Huntington disease (HD) is caused by an abnormally expanded cytosine–adenine– 
guanine (CAG) trinucleotide repeat in the HTT gene. Age and CAG-expansion number 
are related to age at diagnosis and can be used to index disease progression. However, 
observed onset-age variability suggests that other factors also modulate progression. 
Indexing prodromal (pre-diagnosis) progression may highlight therapeutic targets by 
isolating the earliest-affected factors. We present the largest prodromal HD application 
of the univariate method voxel-based morphometry (VBM) and the first application of 
the multivariate method source-based morphometry (SBM) to, respectively, compare 
gray matter concentration (GMC) and capture co-occurring GMC patterns in control 
and prodromal participants. Using structural MRI data from 1050 (831 prodromal, 219 
control) participants, we characterize control-prodromal, whole-brain GMC differences 
at various prodromal stages. Our results provide evidence for (1) regional co-occurrence 
and differential patterns of decline across the prodrome, with parietal and occipital dif-
ferences commonly co-occurring, and frontal and temporal differences being relatively 
independent from one another, (2) fronto-striatal circuits being among the earliest and 
most consistently affected in the prodrome, (3) delayed degradation in some move-
ment-related regions, with increasing subcortical and occipital differences with later pro-
gression, (4) an overall superior-to-inferior gradient of GMC reduction in frontal, parietal, 
and temporal lobes, and (5) the appropriateness of SBM for studying the prodromal HD 
population and its enhanced sensitivity to early prodromal and regionally concurrent 
differences.
Keywords: disease progression, gray matter concentration, humans, magnetic resonance imaging, movement 
disorders, multivariate methods, prodromal symptoms
inTrODUcTiOn
Huntington disease (HD) is a progressive, heritable condition most frequently associated with 
involuntary movements, and also characterized by impairments in executive functioning (1–3), 
recognition of negative facial expressions (4), and odorants (5), reward and punishment processing, 
and impulsivity (6). It is caused by an abnormally large cytosine–adenine–guanine (CAG) repeat 
TaBle 1 | Participant demographics.
caP group N (male/female) Mean age ± sD in years Mean years of education ± sD Mean cag-repeat number ± sD
Control 219 (82/137) 46.1 ± 11.9a 14.8 ± 3.0d 20.1 ± 3.5
Low 216 (72/144) 34.6 ± 9.0 a–c 14.1 ± 3.7 41.0 ± 1.9
Medium 284 (108/176) 41.5 ± 9.9 a–c 14.6 + 2.9 42.1 ± 2.2
High 331 (130/201) 45.9 ± 10.5b 14.0 ± 3.5d 43.6 ± 9.4
Participant CAP groups with mean age, years of education, and CAG-repeat number ± the SD.
aThe mean age of the control group was significantly greater than that of the medium and low groups.
bThe high group mean age was significantly greater than that of the medium and low groups.
cThe medium group was significantly older than the low group.
dThe control group had significantly more years of education than the high group.
Significant differences are not displayed for CAG-repeat number, as CAP group is based on CAG-repeat number, and is thus expected to significantly differ among prodromal 
groups.
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expansion on the HTT gene. Age at motor diagnosis (7–9) and 
rate of disease development (10) are related to CAG-expansion 
and can be used to index the prodromal (pre-diagnosis) period; 
greater expansion numbers are associated with earlier onset and 
more rapid progression. Persons with fewer than 36 CAG-repeats 
are not at risk of HD; the range of 36–39 is not fully penetrant, 
as individuals can die of other natural causes. CAG-expansion 
is fully penetrant for 40 or more repeats, as individuals in this 
range will develop diagnosable symptoms if they reach a sufficient 
age (1). Despite progress in elucidating the mechanisms of HD, 
there is currently no cure. Identifying brain regions and func-
tions impacted at the earliest pre-diagnosis stages is crucial for 
developing therapies to halt or reverse this tragic condition.
The current analyses use the PREDICT-HD dataset (11) to 
examine patterns of gray matter concentration (GMC) reduction 
in prodromal HD. PREDICT-HD is a multisite study containing 
possibly the largest collection of imaging data from individuals 
at various prodromal progression stages (9). We present the first 
application of multivariate source-based morphometry (SBM) 
and the largest application of univariate voxel-based morphom-
etry (VBM), to a prodromal HD population, using a subset of 
1050 PREDICT-HD participants to characterize GMC across the 
prodrome. VBM allows whole-brain, voxel-by-voxel concentra-
tion or volume comparisons (12) and has previously been applied 
to smaller prodromal HD populations [see Lambrecq et al. (13) 
meta-analysis for GMC and Dogan et al. (14) meta-analysis for 
GM volume]. Most of these studies did not stage the prodrome 
or included symptomatic HD patients, precluding identification 
of the earliest-affected factors.
Source-based morphometry, by contrast, is a multivariate 
approach that performs independent component analysis (ICA) 
on the same segmented structural images used for VBM, to exam-
ine co-occurring GMC patterns (15). Like VBM, SBM is benefi-
cial for examining changes across the whole brain, rather than 
being limited to regions of interest. Unlike VBM, SBM is capable 
of determining the co-occurrence of gray matter differences in 
various areas of the brain. It is also more robust at localizing these 
changes (15, 16). SBM has been successfully applied to other clini-
cal populations, including movement disorders such as multiple 
sclerosis (17) and Parkinson’s disease (18). It has also been used 
to study schizophrenia (16, 19–25) and Alzheimer’s disease (26), 
which share key features with HD, such as delayed onset, regional 
and cellular selectivity of atrophy, and cognitive abnormalities. 
Additionally, SBM may be more sensitive than previous methods 
to earlier and more widespread structural differences (15, 16, 
21, 27). It also ameliorates the multiple comparisons problem by 
decreasing the number of maps being tested for group differences 
and can capture noise in the data as separate components that 
can be easily removed (16, 25). The ability to capture patterns of 
covariation enables exploration of the diffusivity or specificity of 
anatomical changes (17), extending interpretation beyond what 
regions are affected to identification of regions that are affected 
together.
We predict an overlap between significant regions in SBM and 
VBM results, with SBM revealing a greater number of affected 
regions, particularly in the early prodrome. We anticipate differ-
ences in these components not only between cases and controls 
but also among different prodromal levels. We expect the caudate 
to be among the most significantly affected regions, grouped in 
a component with functional and spatial neighbors, such as the 
putamen, thalamus, and cortex. Other significant components 
are expected to also include functionally related regions.
MaTerials anD MeThODs
Participants
A total of N =  1292 (1016 prodromal and 276 control) par-
ticipants were analyzed. Of these, 242 were excluded because of 
conversion to HD diagnosis (N = 82) or relatedness to another 
participant (N = 160). The remaining dataset included 1050 indi-
viduals (Table 1): 831 prodromal (521 females, mean age = 40.94, 
SD =  10.86, range 18.84–71.27; 310 males, mean age =  42.23, 
SD = 10.82, range 20.06–82.53) and 219 controls (137 females, 
mean age = 46.27, SD = 10.86, range 20.38–68.61; 82 males, mean 
age = 45.90, SD = 13.59, range 19.15–85.74).
All PREDICT-HD participants provided written, informed 
consent and were treated in accordance with protocols approved 
by each participating institution’s internal review board. All 
participants underwent genotyping prior to study enrollment. 
Healthy controls had fewer than 36 HTT CAG-repeats, while pro-
dromal individuals had more than 35. Exclusion criteria included 
manifestation of any other central nervous system condition or 
unstable medical or psychiatric disorders (1).
Prodromal progression level (low, medium, or high) for this 
study was indexed by a CAP score for each participant’s scanning 
session. CAP is a widely used measure for staging the prodrome 
3Ciarochi et al. Prodromal Huntington Disease Regional Covariance
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and was developed based on an accelerated failure time model 
analysis with the entire PREDICT-HD database. CAP score 
factors age at first session and number of HTT CAG-repeats to 
assess prodromal disease burden [CAP = (age at first measure-
ment) × (CAG − 33.6)]. For the present study, participants were 
classified into low, medium, and high CAP groups based on the 
algorithm described by Zhang et al. (28).
imaging Parameters
High resolution anatomical MR images were collected at 32 col-
lection sites (53 unique scanners) using General Electric, Phillips, 
and Siemens scanners with field strengths of 1.5 T (Tesla) or 3 T, 
using a variety of acquisition parameters. T1 images at each site 
were obtained using three-dimensional (3D) T1-weighted inver-
sion recovery turboflash (MP-RAGE) sequences. Also, 1.5 T scans 
were collected using General Electric and Siemens scanners. The 
Siemens protocol was constructed to be similar to the General 
Electric scan parameters: GRAPPA factor, 900 ms TI (inversion 
time), 2530  ms TR (relaxation time), 3.09  ms TE (excitation 
time), 256 mm × 256 mm field of view (FoV), 10° flip angle, 240 
coronal slices with 1 mm slice thickness, 256 × 128 matrix with 
1/4 phase FoV, 220 Hz/pixel receiver bandwidth. Protocol for 3 T 
scanners commonly involved a sagittal localizing series followed 
by acquisition of an axial 3D volumetric spoiled gradient recalled 
acquisition in steady state (GRASS) sequence, using the follow-
ing scan parameters: ~1 mm × 1 mm× 1.5 mm voxel size, 18 ms 
TR, 3 ms TE, 24 cm FoV, 20° flip angle, 124 slices with 1.5 mm 
slice thickness, 0 mm gap, 256 × 192 matrix with 3/4 phase FoV, 
number of excitations (NEX) of two.
Preprocessing
For each participant, the highest-quality T1 images from the 
earliest available scanning session were used for analyses. Images 
were aligned with the anterior commissure–posterior commis-
sure (AC–PC) plane, resampled with 1 mm isotropic voxels to 
correct for inhomogeneity (29), and preprocessed using the SPM8 
software package.1 All images were segmented into gray matter, 
white matter, and cerebrospinal fluid, unmodulated (to isolate 
GM concentration) and normalized to the same SPM8 Montreal 
Neurological Institute (MNI) template. Voxel intensities of nor-
malized, segmented images represent relative voxel GMC. Image 
voxels were re-sliced to 2  mm ×  2  mm ×  2  mm. Gray matter 
images were smoothed to a full-width-half-maximum (FWHM) 
Gaussian kernel of 10 mm, based on recommendations for using 
high cluster-forming thresholds to reduce false positive rates in 
VBM studies (30). Processed images were 90 × 109 × 91 voxels 
in size.
source-Based Morphometry
Source-based morphometry, using the GIFT Matlab toolbox,2 
was used to apply ICA to preprocessed (segmented, normalized, 
unmodulated, and smoothed) GMC images. The number of 
1 http://www.fil.ion.ucl.ac.uk/spm/software/spm8 
2 http://mialab.mrn.org/software/gift 
components from the 1050 images was estimated to be 23 using 
a minimum description length (MDL) criterion modified to 
account for correlated voxels (31). Each image was converted to 
a one-dimensional vector, yielding one participant-by-voxel data 
matrix. Using the infomax algorithm for spatial ICA, this matrix 
was decomposed into a mixing matrix, representing the relation-
ship between 1050 participants and 23 components, and a source 
matrix, representing the relationship between the 23 components 
and the brain voxels. For the mixing matrix, rows are scores 
signifying how much each of the 23 components contributes to 
one participant’s data, while columns signify how one component 
contributes to each of the 1050 participants. The source matrix 
rows denote the degree to which one component contributes to 
brain voxels, while the columns are scores representing how a sin-
gle voxel contributes to each of the 23 components (15). For each 
participant, the decomposition yields a loading coefficient for 
each component, with each component as a spatial map. ICASSO 
(32) was used to confirm component stability (20 iterations), and 
components were visually inspected to ensure that they primarily 
represented gray matter, rather than white matter or ventricles. 
As all 23 components were stable (with a minimum stability of 
above 0.90 and 21 components above 0.95), each participant had 
23 loading coefficients.
MRI scanner site (53 sites total), gender, and CAP group were 
included as fixed factors, and years of education, age, and age2 were 
included as covariates. To examine the effects of CAP group on 
each SBM structural imaging component, a multivariate analysis 
of covariance (MANCOVA) using the General Linear Model 
(GLM) framework (with 23 dependent variables consisting of 
loading coefficients for each of the components) was executed 
in SPSS (33), followed by a Sidak post hoc test (34), thresholded 
at p ≤ 0.05, to examine specific CAP-group pairwise contrasts. 
The primary contrasts of interest were comparisons of the control 
group with each CAP group (low, medium, and high), as these 
contrasts represent differences between unaffected controls and 
different prodromal progression levels. Other pairwise contrasts 
(GMC in low > medium and medium > high) are included in 
Figure S1 in Supplementary Material.
Voxel-Based Morphometry
Voxel-based morphometry was carried out using SPM83 to com-
pare local average GMC voxel-by-voxel across the entire brain. 
Input files were the same segmented, unmodulated, smoothed 
gray matter images used for SBM. To confirm proper registration 
of participant images to the SPM template, a correlation test was 
run to compare each image to the template. All resulting correla-
tions were between 0.82 (only 5 images) and 0.96 (34 images). 
This is within the normal correlation range for SPM8, with 87% 
of images yielding correlations of 0.9 or higher. As an additional 
check, images with the lowest correlations were inspected using 
SBM’s checkreg. Analyses of CAP-group main effects and all 
pairwise group contrasts were carried out within the GLM frame-
work, using the same covariates used for SBM (age, age2, gender, 
years of education, and scanning site). The main effects of group 
3 http://www.fil.ion.ucl.ac.uk/spm/software/spm8 
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were determined with an F-test, and two-sided t-tests were used 
to compare pairwise group differences. Results were thresholded 
at a family-wise error (FWE) rate of p ≤ 0.05. Both positive and 
negative contrasts were investigated.
statistical analysis
For the SBM analysis, variance equality was confirmed through 
Levene’s test for equality of variance for each SBM component, 
to address the assumption of homogeneity of variance among 
CAP groups. Potential outliers were examined via scatter plots of 
component loading coefficients versus CAP group. Each scanner 
site was investigated for the presence of outliers or unbalanced 
participant demographics, and no such biases were found (see 
Table S2 in Supplementary Material for each site’s participant 
data). Effects of gender and age (independent of disease burden) 
on GMC were accounted for via their inclusion as a fixed factor 
and covariate, respectively, in all analyses. To control for the influ-
ence of age (independent of disease burden) on GMC, age and 
age2 were also included as covariates in all analyses.
resUlTs
Participant demographics at baseline scan are presented in 
Table 1. ANOVA t-contrasts revealed that the control group was 
significantly older than the medium [t501 = 4.79, p < 0.0001] and 
low [t433 = 11.39, p < 0.0001] groups. The high group was also 
significantly older than the medium [t613 = 5.30, p < 0.0001] and 
low groups [t498 = 8.04, p < 0.0001], and the medium group was 
older than the low group [t501 =  4.79, p <  0.001]. The control 
group also had significantly more years of education than the 
high group [t535 = 2.61, p = 0.0092].
Main effect of caP group
There was a statistically significant omnibus effect of the mean 
weighted composite of SBM component loading coefficients 
for CAP group (F69,1990.51 =  3.92, p <  0.0001; Wilk’s Λ =  0.68, 
ηp
2 0 12= . ). The MANCOVA revealed significant effects of CAP 
group on SBM loading coefficients from 12 of the 23 extracted 
components; the spatial maps are shown in Figures  1 and 2 
and the primary brain regions involved in Tables 2 and 3. Each 
component’s loading coefficients displayed a progression gradi-
ent with means in the order of control > low > medium > high 
(Figure 3). The five components with the highest CAP-group sig-
nificance [p < 0.0001; components A ηp2 0 04=( ). , B ηp2 0 092=( ). , 
C ηp
2 0 04=( ). , E ηp2 0 04=( ). , and M ηp2 0 04=( ). ] contained 
neural sources spanning each lobe of the brain, in addition to the 
striatum, with the greatest contributions from frontal and tempo-
ral in addition to striatal areas. A complete list of components and 
encompassing regions is available in Table S1 in Supplementary 
Material.
All VBM results were thresholded at a FWE rate of p ≤ 0.05. 
Similar to the SBM results, the voxel-based F-test within the 
GLM framework revealed widespread gray matter degradation 
throughout disease progression, with the strongest effects in the 
caudate [F3,992 = 124.18, p < 0.0001, z = Inf (left); F3,992 = 131.13, 
p <  0.0001, z =  Inf (right)]. Other regions exhibiting overall 
group differences included inferior frontal orbital [F3,992 = 12.14, 
p =  0.001, z =  5.23 (left); F3,992 =  10.80, p =  0.008, z =  4.87 
(right)], inferior occipital [F3,992 = 9.83, p = 0.028, z = 4.60 (left); 
F3,992 = 9.45, p = 0.044, z = 4.48 (right)], right inferior temporal 
(F3,992 = 9.36, p = 0.050, z = 4.45), hippocampus [F3,992 = 9.36, 
p =  0.049, z =  4.46 (left); F3,992 =  11.97, p =  0.002, z =  5.19 
(right)], left lingual gyrus (F3,992 = 14.97, p < 0.0001, z = 5.93), 
and thalamus [F3,992 = 16, p < 0.0001, z = 6.16 (left); F3,992 = 13.71, 
p < 0.0001, z = 5.63 (right)] (Figure 4).
Pairwise group contrasts
The Sidak post hoc test yielded at least one significant pairwise 
CAP-group contrast for 13 of the 23 SBM components (Figures 3 
and 5). In addition to capturing differences between control and 
prodromal groups, some components demonstrated differences 
between prodromal groups (such as low and medium groups). 
These components may most sensitively capture differences 
within the prodromal period (see Figure S1 in Supplementary 
Material for all supplemental contrasts). VBM pairwise group 
contrasts (Table  4) revealed the greatest group differences in 
contrasts with the high group. VBM pairwise contrast images are 
available in Figure S2 in Supplementary Material.
low-Prodromal group
The Sidak test revealed significant differences between the control 
and low groups in seven SBM components (O: p < 0.001, Cohen’s 
d = 6.2; C: p < 0.001, Cohen’s d = 7.1; J: p = 0.009, Cohen’s d = 4.6; 
G: p = 0.016, Cohen’s d = 4.3; F: p = 0.011, Cohen’s d = 4.5; D: 
p = 0.032, Cohen’s d = 4.1; H: p = 0.046, Cohen’s d = 3.9). These 
components contained contributions from middle and superior 
frontal gyrus (D and C), precentral gyrus and supplementary 
motor (C), occipital (O; G in mid/superior only; F in inferior 
only), calcarine (O and F), cuneus and precuneus (J), fusiform 
(H), superior (J) and inferior temporal (H and F), superior pari-
etal (G), angular gyrus (G and J), and cerebellum crus 1 (F). By 
contrast, no substantial VBM differences were evident between 
control and low groups.
Medium-Prodromal group
Four SBM components were significantly different between the 
control and medium groups (C: p = 0.005, Cohen’s d = 4.8; A: 
p =  0.010, Cohen’s d =  4.5; B: p =  0.020, Cohen’s d =  4.2; D: 
p = 0.039, Cohen’s d = 3.9). These contained caudate and thala-
mus (B), frontal gyrus [superior (C and D), middle (A, C, D)], 
supplementary motor (C), precentral (C), superior temporal (A), 
anterior cingulate (A), and parahippocampal (A). For VBM, the 
medium group had significant reductions relative to controls, but 
only in right caudate (T992 = 5.83, p < 0.0001, Cohen’s d = 0.3) and 
putamen [T992 = 4.98, p = 0.005, Cohen’s d = 0.3 (left); T992 = 4.93, 
p = 0.006, Cohen’s d = 0.4 (right)].
high-Prodromal group
Thirteen SBM components were significantly different between 
the control and high groups [p < 0.0001: components A (Cohen’s 
d = 8.4), B (Cohen’s d = 13.1), C (Cohen’s d = 5.7), E (Cohen’s 
FigUre 1 | components with strongest caP-group significance (p ≤ 0.0001). Multiview topography of Table 2 components, thresholded between Z = 4.0 
and the component’s maximum Z-score (presented in column 3) to optimize display of regions with highest Z-scores.
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d =  7.8), J (Cohen’s d =  6.0), M (Cohen’s d =  7.2); p =  0.001: 
G (Cohen’s d = 5.5); p = 0.005: K (Cohen’s d = 4.7); p = 0.013: 
D (Cohen’s d = 4.3); p = 0.033: H (Cohen’s d = 3.9); p = 0.035: 
N (Cohen’s d = 3.9); p = 0.037: I (Cohen’s d = 3.8); p = 0.041: 
F (Cohen’s d =  3.8)]. Eight of these were significant in earlier 
control-prodromal contrasts (C > L, C > M). The remaining five 
components (E, I, K, M, and N) were not significant in earlier 
contrasts but contained regions within components that were 
significant in these contrasts, including putamen and thalamus 
(Q), mid- and superior-frontal (N), precuneus and calcarine (M), 
and inferior temporal (N, I). These components also contained 
regions not present in other contrasts, including paracentral (E), 
mid cingulum (E), mid temporal (M and I), inferior frontal (M), 
cerebellum 9 (K), right lingual (K), vermis 4, 5, 9 (K), cerebellum 
9 (K), cerebellum crus 2 (K).
For VBM, the high group exhibited differences relative to 
controls in caudate [T992 =  14.51, p <  0.0001, Cohen’s d =  0.9 
(left); T992 = 15.51, p < 0.0001, Cohen’s d = 1.0 (right)], right mid 
frontal (T992 = 4.93, p = 0.006, Cohen’s d = 0.3), right superior 
temporal (T992 =  5.24, p =  0.001, Cohen’s d =  0.3), right and 
left middle temporal [T992 =  5.55, p <  0.0001, Cohen’s d =  0.4 
(right); T992 = 4.56, p = 0.029, Cohen’s d = 0.3 (left)], right and left 
inferior temporal [T992 = 5.13, p = 0.002, Cohen’s d = 0.3 (right); 
T992 = 4.76, p = 0.012, Cohen’s d = 0.3 (left)], right cerebellum 
(T992 =  5.80, p <  0.0001, Cohen’s d =  0.4), and left olfactory 
(T992 = 11.86, p < 0.0001, Cohen’s d = 0.8).
FigUre 2 | additional components with caP-group significance of p ≤ 0.004. Coronal, sagittal, and axial views of Table 3 components, thresholded to 
optimally view regions with maximum Z-scores. Regions displayed in each component have Z-scores between 4.0 and the component’s maximum Z-score, 
displayed in column 3.
6
Ciarochi et al. Prodromal Huntington Disease Regional Covariance
Frontiers in Neurology | www.frontiersin.org September 2016 | Volume 7 | Article 147
Differences across the Prodrome
Components C (precentral gyrus, mid and superior frontal, sup-
plementary motor) and D (middle and superior frontal gyrus) 
exhibited significant differences between the control group and 
each progression group (low, medium, high). Components G 
(superior parietal, angular, mid and superior occipital), H (infe-
rior temporal, fusiform), J (angular gyrus, superior temporal, 
cuneus, precuneus), and F (calcarine, inferior temporal, inferior 
occipital, cerebellum crus 1) were similar but lacked significant 
differences between control and medium groups.
DiscUssiOn
Voxel-Based Morphometry
Our VBM GMC results coalesce well with existing literature. 
While many VBM studies have examined gray matter volume 
(GMV), one meta-analysis (13) compiled GMC VBM findings 
in prodromal and diagnosed HD. The GMC meta-analysis con-
densed 11 studies (297 patients and 205 controls) and reported 
a prodromal consensus on reductions in the left putamen and 
right inferior frontal gyrus (IFG) relative to controls. We repli-
cated these findings in our PREDICT-HD sample and also found 
bilateral differences in caudate, thalamus, inferior frontal, hip-
pocampus, and inferior occipital. Left lingual and right inferior 
temporal were also significantly affected.
According to the meta-analysis, symptomatic (but not pro-
dromal) HD patients differed from controls in the left caudate 
body, left IFG, and right middle frontal gyrus, all of which 
were significant in our prodromal-control and prodromal level 
comparisons. This regional overlap is unsurprising; Although 
PREDICT-HD does not include HD cases, its incorporation 
of over twice as many participants as the meta-analysis lends 
increased statistical power. This explanation is bolstered by 
the particular prominence of these regional differences in our 
medium > high contrast, which suggests that these regions may 
be among the most dramatically affected in the late prodrome. 
Notably, the meta-analysis reported that HD (but not prodro-
mal) patients consistently had reduced caudate GMC compared 
TaBle 3 | additional sBM components with caP significance of p ≤ 0.004.
component caP effect statistic (F3,688) Most significant regions left/right volume (cc) left/right maximum Z coordinates (x, y, z)
G 5.650 Superior parietal 4.0/3.8 5.8 (−26, −71, 52)/5.0 (28, −70, 53)
Angular gyrus 2.8/2.9 5.0 (−43, −65, 50)/4.6 (45, −59, 53)
Left mid occipital 1.4 4.8 (−31, −80, 41)
Left inferior parietal 0.4 4.3 (−35, −78, 41)
J 6.805 Right angular 1.2 5.2 (53, −48, 25)
Superior temporal 7.7/7.1 4.9 (−58, −12, 1)/4.8 (51, −47, 21)
Right precuneus 4.0 4.6 (14, −65, 24)
Right superior temporal 2.9 4.6 (14, −65, 24)
Right cuneus 1.2 4.4 (21, −65, 26)
O 9.418 Superior 6.5/6.5 8.1 (−7, −101, 9)/7.6 (17, −98, 3)
Occipital/calcarine 0.9/1.1 6.5 (−12, −97, −3)/5.4 (32, −95, −0)
Calcarine/inferior occipital 1.0/1.9 6.3 (−5, −97, 21)/6.0 (10, −95, 23)
Occipital/calcarine 0.3/0.3 4.7 (−25, −96, 3)/5.9 (27, −93, 2)
D 3.88 Middle frontal 5.0/7.2 5.1 (−30, 57, 12)/6.0 (30, 54, 21)
Superior frontal 8.3/11.3 5.1 (−30, 50, 25)/5.9 (30, 55, 17)
Medial frontal 0.4/1.2 4.9 (−10, 65, 12)/5.1 (10, 65, 12)
Regions within components G, J, O, and D (CAP-group significance of p ≤ 0.004), with CAP effect F statistics from the Sidak post hoc, bilateral maximum Z scores, and 
corresponding MNI coordinates and volumes.
TaBle 2 | sBM components with strongest caP-group effects (p ≤ 0.0001).
component caP effect statistic (F3,688) Most significant regions left/right volume (cc) left/right maximum Z coordinates (x, y, z)
A 12.1915 Superior temporal pole 2.4/2.3 7.4 (−38, 13, −24)/7.2 (44, 16, −25)
Superior temporal 2.8/2.2 5.8 (−49, −3, −3)/5.9 (51, 1, −8)
Anterior cingulate/medial 1.7/2.2 5.1 (1, 44, 11)/5.7 (3, 50, −4)
Frontal parahippocampal 0.3/0.2 3.9 (−14, −4, −23)/4.0 (18, 1, −24)
B 37.733 Caudate 3.8/3.9 12.5 (0.10, 17, 5)/11.6 (14, 20, 4)
Thalamus 1.8/2.1 8.7 (−5, −13, 16)/8.3 (10, −15, 16)
C 11.948 Precentral/mid frontal 6.9/5.3 5.2 (−37, −6, 62)/4.9 (43, −4, 60)
Precentral/superior frontal 4.2/2.7 4.6 (−34, −1, 55)/4.6 (30, −2, 63)
Supplementary motor 1.1/1.0 4.2 (−5, −7, 66)/4.1 (13, −0, 66)
E 11.873 Supplementary motor 2.9/5.4 7.7 (2, 15, 49)/6.2 (6, 15, 47)
Frontal superior 0.3/0.1 5.5 (0, 31, 33)/2.8 (2, −72, 31)
Medial/cuneus 4.6/3.4 7.1 (2, −33, 60)/6.4 (6, −31, 58)
Paracentral lobule 3.6/3.2 7.0 (2, −33, 60)/5.8 (6, 11, 46)
Mid cingulate/precuneus 4.0/5.1 5.6 (2, −42, 56)/5.5 (6, −44, 62)
M 9.220 Calcarine 0.6/7.2 4.7 (−25, −60, 7)/10.6 (27, −50, 13)
Left precuneus 1.9 6.9 (−25, −51, 14)
Left mid temporal 1.0 4.5 (−46, −51, 12)
Left superior occipital 0.5 4.1 (−20, −68, 20)
Regions within components A, B, C, E, and M, including CAP-group effect F statistic derived from the Sidak post hoc, bilateral maximum Z scores with corresponding Montreal 
Neurological Institute (MNI) coordinates, and volumes in cubic centimeters (cc).
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to control (and prodromal) subjects. The meta-analysis did not 
stage the prodrome, and the few studies it included that did 
index the prodrome had far fewer participants than the present 
study. In our large sample, we did not detect any VBM differences 
between the earliest prodromal group and the control group, and 
this may highlight the heterogeneity of the prodromal popula-
tion. If a study considers the prodrome as a whole, yet has a 
disproportionate representation of early or late prodromal cases, 
certain differences may fail to replicate in many studies. This 
may be further compounded by methodological and parameter 
differences among studies, as well as individual participant trait 
differences across sites.
Our results align with those reported in the meta-analysis; how-
ever, its authors conclude that the data support a left-hemispheric 
degradation bias that extends bilaterally at the symptomatic stage. 
For their data, this is evident in the striatum, as the putamen 
and caudate demonstrated only left-hemispheric consensus sig-
nificance. However, it is less supported by their results in other 
regions; right IFG was significant for the prodromal <  control 
contrast, while left IFG was significant only in the HD < control 
condition. This would appear to suggest initial right-hemispheric 
changes in certain regions, which is supported by our findings. 
We observed stronger left-hemisphere effects in earlier prodro-
mal contrasts in inferior frontal, putamen, thalamus, and inferior 
FigUre 3 | caP-group differences in sBM loading coefficients. Significant pairwise group contrasts in CAP-group-significant components, derived from the 
Sidak post hoc test. Comparisons labeled with a single asterisk (*) denote significance of p ≤ 0.05; comparisons labeled with two asterisks (**) denote significance 
of p ≤ 0.0001.
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occipital, and significant findings in olfactory and lingual were 
limited to the left hemisphere. However, we also observed differ-
ences that were restricted to the right hemisphere in mid frontal, 
superior temporal, and cerebellum, as well as right-hemispheric 
differences preceding those in left-hemispheric mid/inferior tem-
poral, hippocampus, and caudate (although caudate effects were 
FigUre 4 | group main effects (ancOVa F contrast). Main effects of CAP group on VBM, showing regions that vary throughout the prodrome (p ≤ 0.05). 
Global maximum: x = 10.00, y = 12.00, z = 6.00; F3,992 = 131.13. The colored bar legend codes the F statistic at each voxel, with white areas denoting voxels with 
the highest significance levels.
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overall bilateral). These results appear to support a hemispheric 
effect with regional variability.
source-Based Morphometry
Our SBM analysis revealed patterns both complementary to 
and distinct from those reported in previous VBM studies. 
Many imaging phenotypes were most reduced in the high 
CAP group (closest to diagnosis) and least perturbed in the 
low group, consistent with a low-to-high prodromal disease 
gradient. Both SBM and VBM identified strong GMC reduc-
tions in the high-prodromal progression group. Differences 
between control and low groups were present in several SBM 
components but were absent from VBM results, consistent 
with previous VBM–SBM comparison studies in which results 
were comparable, but SBM yielded additional regions that 
were not uncovered with the univariate method (16, 21, 25). 
This could indicate, as others have suggested (15, 16, 21), that 
multivariate SBM is more sensitive to early clinical differences 
in certain populations than similar univariate methods, such 
as VBM.
As the first application of SBM to prodromal HD, our results 
constitute novel evidence for SBM’s enhanced sensitivity to early 
prodromal HD differences. This benefit may be afforded by the 
inter-subject-variability present in heterogeneous clinical popula-
tions, such as prodromal HD, where differential CAG-expansion 
number and age confer a range of phenotypic severity in the 
population. A similar explanation was offered by the authors 
of a first-episode schizophrenia study in which SBM, but not 
VBM, yielded significant differences from controls (21); this was 
attributed to the heterogeneity of first-episode schizophrenia 
patients and the noise-dependency of the VBM method, both 
of which could be exacerbated by methodological problems or 
preprocessing differences.
In addition to early sensitivity, SBM may detect more wide-
spread concentration differences throughout the prodrome. The 
SBM results captured each region present in the VBM results, as 
well as several other regions that were not detected with VBM 
(including thalamus, superior frontal, frontal inferior trigeminal, 
precentral, superior/inferior parietal, parahippocampal, hip-
pocampus, precuneus, occipital, calcarine, lingual, fusiform, 
cuneus, anterior/mid cingulate, supplementary motor, paracen-
tral lobule, fusiform, and areas in the vermis and cerebellar lobule 
VI). Furthermore, each region within the SBM components that 
yielded the greatest control-low differences (such as frontal 
regions) was only significant in VBM contrasts involving more 
advanced progression groups. This may be explained by SBM’s 
ability to integrate covarying brain regions and capture network-
level differences, which contrasts with VBM’s focus on individual 
voxels that more robustly captures differences in small regions 
with few voxels.
FigUre 5 | sBM components and pairwise contrasts. SBM regions 
significant in control > low, control > medium, and control > high contrasts. 
Pairwise contrasts are provided in Figure S1 in Supplementary Material. 
Regions are grouped into boxes, with each box representing a component 
that was significant in the contrast. Components are ordered by descending 
Sidak significance for the contrast (p-value). Regions within components are 
listed in descending order of their contribution to the component (Z-score). 
Dark gray boxes denote components/regions that were significant in all three 
contrasts, light gray boxes are components/regions that were significant in 
two contrasts, and white boxes (present only in the control > high contrast) 
contain components/regions that were significant in only the one contrast. 
Bolded regions within white boxes signify regions that did not appear in any 
other significant component/contrast.
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The SBM results also provide insight regarding regions that are 
changing together, covariation that is captured by SBM’s grouping 
of regions into the same component. In many cases, regions within 
components were spatial or functional neighbors, exemplified by 
the presence of both the caudate and thalamus in component B; 
these regions work in concert with the subthalamic nucleus and 
substantia nigra to subserve coordinated voluntary movement 
(35). Frontal regions, in particular, tended to be grouped within 
the same components. Temporal regions were also more likely 
to dominate components than parietal and occipital regions, 
which were frequently grouped together. This may suggest that 
frontal and temporal regions change more independently from 
each other, while parietal changes may more frequently impact 
occipital areas and vice  versa. While the components do not 
represent networks per  se, the concurrence of these regional 
differences may highlight network-level changes by pinpointing 
areas where differences tend to coincide in participants. In light 
of the comparability, overlap, and extension of the VBM results 
present in the SBM results, the remainder of the discussion will 
focus on SBM component pairwise comparisons.
Differences across the Prodrome
Two components (C and D) were sensitive to differences from 
controls at all three prodromal stages. Interestingly, both of these 
were dominated by frontal regions (superior frontal, mid/medial 
frontal, precentral, and supplementary motor). These areas may 
begin to change early in prodromal development and continue 
to be affected throughout its course, potentially making them 
appealing targets for early and ongoing interventions.
early Prodromal Differences 
(control > low)
Many SBM components exhibited differences between the 
control and low-prodromal groups, indicating widespread GMC 
loss even at early prodromal stages. The most commonly signifi-
cant regions in this contrast were superior frontal, mid frontal, 
angular gyrus, and inferior temporal (each in two components). 
Overall, the strongest early effects were frontal (Component 
C: superior/mid/medial frontal, precentral, supplementary 
motor; Component D: superior/medial frontal). These areas are 
functionally relevant to HD, with supplementary motor cortex 
being integral to movement planning and coordination, and 
the precentral gyrus containing primary motor cortex (M1). 
A recent study examining prodromal functional connectivity 
of M1 reported that increased CAG-expansion was associated 
with reduced M1 connectivity with postcentral gyrus (primary 
somatosensory cortex) and visual centers in the cuneus (36). This 
could be accompanied by or related to gray matter degradation 
in these regions, aligning with their presence in group-significant 
SBM components. Component O, which contained widespread 
occipital and calcarine, was also highly affected in the early 
prodrome, consistent with reports of complex visual integration 
deficits being particularly discriminatory between symptomatic 
and prodromal individuals (37). The next most strongly affected 
component (J) contained cuneus, precuneus, superior temporal, 
and angular gyrus, possibly reflecting an early disruption of the 
default-mode network (which includes precuneus, angular gyrus, 
and temporal areas) (38). This component also implicates striatal 
pathways; the cuneus is connected to the angular gyrus, which 
associates with superior frontal regions and the caudate via the 
occipitofrontal fasciculus (39, 40).
later Prodromal Differences
Source-based morphometry first detected significant caudate and 
thalamus differences in the control > medium contrast (compo-
nent B). Aside from the caudate, dorsomedial and anteroventral 
TaBle 4 | T statistics and coordinates (x, y, z) for regions significant in VBM pairwise contrasts.
region Brodmann area cluster size Peak p Peak T Talairach coordinates
control > medium contrast
Right caudate 25 268 <0.0001 5.83 (8, 10, 4)
Left putamen 48 0.005 4.98 (−6, 10, 2)
Right putamen 48 23 0.006 4.93 (22, 14, 4)
control > high contrast
Right caudate 25 26,289 <0.0001 15.51 (10, 12, 6)
Left caudate 25 <0.0001 14.51 (−8, 10, 4)
Left olfactory – <0.0001 11.86 (0, 8, 8)
Right cerebellum 6 – 303 <0.0001 5.8 (8, −74, 16)
Right mid temporal 21, 37 504 <0.0001 5.55 (56, −4, −18)
Right superior temporal 22 0.001 5.26 (−32, 36, −20)
Right inferior temporal 37 139 0.002 5.13 (48, −48, −24)
Right mid frontal 10, 46, 8 56 0.006 4.93 (−30, 56, 8)
Left inferior temporal 20 22 0.012 4.76 (−64, −44, −14)
Left mid temporal 22, 37 15 0.029 4.56 (−64, −26, −4)
Significant regions in VBM pairwise contrasts. Significant regions with corresponding Brodmann areas, cluster sizes (in voxels), peak p-values, peak T-values, and Talairach 
coordinates are provided for VBM control > high-prodromal (near onset) and control > medium-prodromal contrasts. Values in front of parentheses are T992 scores; numbers inside 
parentheses are MNI coordinates (x, y, z).
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thalamic regions were the strongest contributors to this com-
ponent. These subdivisions project to prefrontal and temporal 
cortices, respectively (41), both of which were also significant 
in this contrast (Components A, C, D). This thalamo-cortical 
projection is important for motor control, sensory relay (42), 
and many aspects of executive functioning (43), congruent with 
reported executive functioning impairments that worsen with 
increased prodromal progression.
The control  >  high-prodromal contrast captured each 
component that was significant in earlier prodromal contrasts. 
Within the five components that were not significant until the 
control > high contrast, many represented brain regions were also 
present in significant components from earlier prodromal con-
trasts, including precentral, calcarine, mid/superior frontal, and 
inferior/mid temporal. By contrast, late prodromal differences in 
the absence of earlier differences occurred in paracentral, mid 
cingulum, mid temporal, inferior frontal, lingual, vermis (4, 5, 9), 
and cerebellum crus 2. This suggests that, while many areas are 
affected early in the prodrome and continue to change through-
out it, other (notably subcortical) regions may be substantially 
affected only at later prodromal stages. Several of these regions 
are important for motor performance, which is subtly affected in 
the early prodrome but declines steeply close to diagnosis-onset 
(1). The paracentral lobule, for example, interacts with supple-
mentary motor cortex and distal limbs for somatosensation and 
is among regions that demonstrate reduced activation during 
processing of emotional faces in HD patients. The cingulum 
presents another example; the anterior cingulate (Component A) 
demonstrated intermediate and late prodromal differences, while 
the mid cingulate (Component E) only showed late differences. 
Anterior cingulate is involved in emotional regulation and has 
been implicated in depression and apathy (44), which co-occur 
in HD (1, 45, 46). Mid cingulate, by contrast, innervates premotor 
and motor cortical areas (47) and may contribute to increasing 
motor deficits with later prodromal progression.
summary
Frontal components were sensitive to early, intermediate, and 
late prodromal stages, with differences beginning earliest and 
remaining strongest in superior and mid frontal areas. Frontal 
differences were first observed (control > low contrast) in precen-
tral, supplementary motor, and mid and superior frontal regions 
that tended to be grouped in the same components. These may be 
among the most continuously affected regions in prodromal HD.
Inferior frontal trigeminal was the only affected inferior frontal 
region and exhibited differences only in the late prodromal con-
trast. A similar pattern was observed in inferior temporal, which 
was much more typical and significant in the late compared to 
early prodromal contrast. Superior temporal and angular gyrus 
also displayed robust early prodromal differences that continued 
into the mid and late prodrome, while inferior parietal was absent 
from the results entirely. Overall, this suggests a superior-to-
inferior gradient of GM degradation across the prodrome, with 
the exception of the occipital lobe (both superior and inferior 
occipital were significant in early and late contrasts).
Many occipital and subcortical regions did not exhibit con-
centration differences until the late prodromal stage, including 
cerebellum crus 2, vermis 4, 5, 9, right lingual gyrus, and mid 
cingulum. Significant inferior frontal trigeminal, mid temporal, 
and paracentral lobule effects were also limited to this contrast. 
This delayed contribution of regions important for movement is 
in accordance with motor impairment as the primary instigator of 
diagnosis, as well as the observed non-linear prodromal pattern 
of motor functioning that culminates with sudden deterioration 
in the late prodrome (1).
The overlap between results from SBM and VBM (the latter of 
which has been applied in other prodromal HD studies) suggests 
that SBM is suitable for studying this population. Consistent with 
previous findings in other clinical populations (15, 16, 21), SBM 
appeared to detect concentration differences at earlier progression 
stages and in more regions than VBM. Furthermore, the grouping 
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of regions into SBM components highlights covarying areas that 
may be good targets for investigating network-level changes.
limitations
There are a number of important factors to consider while 
interpreting these results. In any study involving a large number 
of participants with a rare condition, multiple scanning sites 
are typical, and thus a certain degree of inhomogeneity in data 
collection is inevitable. This study used data from several unique 
1.5 or 3 T scanners. Every effort was made to control for pos-
sible confounds relating to multiple collection sites. Uniform 
protocols were established to ensure maximal homogeneity of 
data collection, and field strength was included as a fixed factor 
in all analyses. As described in the Section “Statistical Analysis,” 
collection sites were examined for outliers and unbalanced 
participant demographics (site demographics are provided in 
Table S2 in Supplementary Material). It is also worth noting that 
a study investigating scan parameter effects on SBM components 
from a multisite schizophrenia study found that site effects were 
successfully eradicated with both GLM (VBM) and SBM cor-
rection (48).
Given the dramatic striatal role in HD, the lack of significant 
differences between the control- and low-prodromal groups in the 
caudate/thalamus component was surprising. This component 
was strongly significant in every other pairwise contrast (includ-
ing supplemental contrasts low > medium and medium > high), 
indicating that SBM robustly captured prodromal progression 
in these regions. Additionally, as exemplified by the VBM GMC 
meta-analysis, caudate differences are not always found in the 
earliest prodromal contrasts (although this does not seem to 
be the case in volumetric analyses). Concentration measures 
may capture subtler changes in underlying cellular mechanisms 
that are not yet reflected by structural volumes, which may also 
underlie other dissimilarities between GMV and GMC results. 
Nonetheless, we investigated possible explanations for this find-
ing. Although the SBM components were examined for and did 
not appear to contain artifacts, prodromal individuals may have 
smaller intracranial volumes (ICV) than controls (49), and it is 
important to investigate the possibility that ventricular artifacts in 
some components could mask GMC reduction. Unsurprisingly, 
ICV was significantly correlated with 19 of the 23 SBM com-
ponents. However, when ICV was included as an additional 
covariate in the SPSS MANCOVA analysis, it did not substan-
tially change either the MANCOVA results or the Sidak post hoc 
results (7 components were still significant for control >  low, 4 
for control > medium, and 11 for control > high). ICV also did 
not alter the caudate component effects, which was of particular 
concern given the unexpected lack of control > low significance. 
It may also be possible for subtle head motions that are undetect-
able during data collection to influence results (50), an inevitable 
possibility in any study investigating movement disorders using 
motion-sensitive equipment. While it was not possible to address 
this with the current dataset (beyond behavioral data and motion-
correcting preprocessing steps), we aim to investigate possible 
motion effects using measures of framewise displacement from 
resting state data, available for some participants.
Source-based morphometry components generally fol-
lowed an expected pattern of control > low > medium > high. 
However, the finding that seven components were significant 
for the control >  low contrast compared to four for the con-
trol >  medium contrast was an unexpected, but not totally 
unprecedented finding. Cognitive and clinical findings in the 
medium-prodromal group have also been less consistent than 
in the other groups (9). Explanations for these differences have 
varied; some have suggested potential protective effects in 
the early prodrome, aligning with observations of compensa-
tory increased task-based connectivity and activity during 
performance of certain tasks (51). Even pathological nuclear 
protein aggregation is suspected of having a protective role, 
as it does not correlate well with disease symptoms or onset 
(52). Inconsistent group results could also reflect an imperfect 
parsing of prodromal groups, highlighting an underlying 
goal of this study (pinpointing additional sources of variation 
beyond CAG-expansion and age). We attempted to control for 
important group differences (like age) that could skew results. 
Additionally, our group and others are working to develop 
“risk scores” that encapsulate other factors in onset variability. 
However, the present heterogeneity in the medium group may 
account for some unexpected findings.
cOnclUsiOn anD FUTUre DirecTiOns
Our findings support the utility of SBM for investigating pro-
dromal HD. The results reinforce the acknowledged widespread 
nature of neural degradation in HD, with reduced GMC being 
evident across the entire brain rather than isolated to the 
striatum. They also provide insight into patterns of atrophy and 
concurrently affected regions; frontal and temporal areas differed 
relatively independently compared to (often co-occuring) pari-
etal and occipital differences. Additional evidence was uncovered 
for differential patterns of decline across the prodrome, with the 
earliest differences affecting more superior areas, intermediate 
differences increasing in middle regions, and later differences in 
more inferior, occipital, and subcortical structures.
Future research would benefit from exploiting the increased 
sensitivity of morphometric techniques like SBM to address 
questions regarding how subtle structural differences relate to 
cognitive, motor, and psychiatric functioning. The parsing tech-
nique inherent in SBM can also be used to investigate differences 
between prodromal white and gray matter changes. Furthermore, 
it is possible that differences in HTT and other genes in the HD 
signaling pathway (53) underlie some observed structural dif-
ferences. Investigation of genotypes associated with structural 
phenotypes may elucidate markers of disease progression that 
are present earlier than detectable deficits on clinical batteries.
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